In vivo anti-tumor activity of combinati
โ
Michael J. Brunda; Donna Bellantoni; Viveca Sulich
๐
Article
๐
1987
๐
John Wiley and Sons
๐
French
โ 684 KB
The in vivo anti-tumor activity of 2 recombinant cytokines, interleukin-2 (rlL-2) and human hybrid interferon alpha (rHulFN-aA/D), were tested using the murine reticulum cell sarcoma M5076. Experimental hepatic metastases, following i.v. injection of tumor cells, and tumor growth and spontaneous met